ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0750
-0.0020 (-2.60%)
At close: Aug 26, 2026
ReNerve Market Cap
ReNerve has a market cap or net worth of 12.92 million as of August 26, 2026. Its market cap has decreased by -9.81% in one year.
Market Cap
12.92M
Enterprise Value
8.90M
Revenue
333.21K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 12.92M, a decrease of -52.05%. That is a compound annual growth rate of -34.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 12.92M | -21.90% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EZZ Life Science Holdings | 24.48M |
| Algorae Pharmaceuticals | 22.28M |
| Patrys | 20.67M |
| Neurotech International | 15.81M |
| Ceryvyn Therapeutics | 15.05M |
| Cambium Bio | 12.36M |
| Immuron | 12.09M |
| AdAlta | 11.24M |